REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $113,000 | -93.8% | 2,690 | -94.2% | 0.00% | -93.8% |
| Q2 2021 | $1,814,000 | +13.9% | 46,690 | 0.0% | 0.03% | +23.1% |
| Q1 2021 | $1,593,000 | +575.0% | 46,690 | +797.9% | 0.03% | +550.0% |
| Q4 2020 | $236,000 | +65.0% | 5,200 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $143,000 | -25.5% | 5,200 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $192,000 | +14.3% | 5,200 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $168,000 | -21.1% | 5,200 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $213,000 | +15.1% | 5,200 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $185,000 | 0.0% | 5,200 | +44.4% | 0.00% | 0.0% |
| Q2 2019 | $185,000 | -10.2% | 3,600 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | -51.3% | 3,600 | -50.0% | 0.00% | -20.0% |
| Q4 2018 | $423,000 | +55.5% | 7,200 | +100.0% | 0.01% | -16.7% |
| Q3 2018 | $272,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
| MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
| Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
| ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
| Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
| MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
| WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
| Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
| SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
| Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |